Fairmount Funds Management LLC 13D and 13G filings for Kiniksa Pharmaceuticals, Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 3:46 pm Purchase |
2023-12-31 | 13G | Kiniksa Pharmaceuticals, Ltd. KNSA |
Fairmount Funds Management LLC | 2,883,221 8.100% |
740,169 (+34.54%) |
Filing |
| 2023-08-10 4:15 pm Purchase |
2023-08-02 | 13G | Kiniksa Pharmaceuticals, Ltd. KNSA |
Fairmount Funds Management LLC | 2,143,052 6.100% |
2,143,052 (New Position) |
Filing |